ZMDKOTYRWPJHEE-GXZWQRSESA-N
C24H22ClF4N7O2S2 — CID 155380633
Data last refreshed: (MolForge compound catalog, from PubChem)
About ZMDKOTYRWPJHEE-GXZWQRSESA-N
ZMDKOTYRWPJHEE-GXZWQRSESA-N (PubChem CID 155380633) has the molecular formula C24H22ClF4N7O2S2 and a molecular weight of 616.07 g/mol. Its IUPAC name is (3S)-N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-3-fluoropyrrolidine-1-sulfonamide.
Molecular Properties
| Compound Name | ZMDKOTYRWPJHEE-GXZWQRSESA-N |
|---|---|
| PubChem CID | 155380633 |
| Molecular Formula | C24H22ClF4N7O2S2 |
| Molecular Weight | 616.07 g/mol |
| Exact Mass | 615.09 |
| IUPAC Name | (3S)-N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-3-fluoropyrrolidine-1-sulfonamide |
| SMILES | O=S(=O)(N[C@H]1CC2=C(c3ccn(C(F)F)n3)[C@H](c3ccc(F)cc3Cl)N=C(c3nccs3)N2C1)N1CC[C@H](F)C1 |
| InChI | InChI=1S/C24H22ClF4N7O2S2/c25-17-9-13(26)1-2-16(17)21-20(18-4-7-36(32-18)24(28)29)19-10-15(33-40(37,38)34-6-3-14(27)11-34)12-35(19)22(31-21)23-30-5-8-39-23/h1-2,4-5,7-9,14-15,21,24,33H,3,6,10-12H2/t14-,15-,21-/m0/s1 |
| InChIKey | ZMDKOTYRWPJHEE-GXZWQRSESA-N |
| XLogP | 4.39 |
| TPSA | 95.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 616.07 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155380633 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.